EFPIA - NEWSLETTER

EFPIA Newsletter 15 June 2023

Pharma reform: Patients can’t afford to wait. Act now.

Waiting five years to try and fix patient access while we watch EU competitiveness...

In POLITICO, Nathalie Moll, EFPIA Director General outlines how, together, we can evolve the new EU pharmaceutical legislation to make a difference, to back innovation and boost access in Europe.

News

12 June 2023 IHI Calls 4 and 5: Publication of draft topics and opening of registration to call days

IHI Call Days: Calls 4 & 5

Blog

15 June 2023 Industry disclosure of payments to health professionals and patients: Improving access to data...

EFPIA launches a new European gateway, an easy-to-navigate platform which connects all information disclosed by EFPIA...

15 June 2023 Shared decision making in kidney cancer: combining clinical evidence and patient preference...

This year, we will continue to not only raise awareness of the importance of shared decision making in kidney cancer,...

14 June 2023 The patient expert who lived with an antimicrobial resistant infection for 15 years before...

Experience of living with Cystic Fibrosis (CF) and the impact AMR on one's health journey and the wider CF patient community...

12 June 2023 How is your country treating your heart?

A set of CVD data across 22 European countries to see how CVD trends have developed over time, the existing disparities...

Events

22 JUN 2023

How the pharmaceutical industry is working to avoid and replace the use of animals... Zoom

An online event co-organised by EFPIA and the RSPCA

Learn more →

19 JUN 2023

IHI Call Days: Calls 4 & 5 Online

The aim of the IHI Call Days is to provide potential applicants with the information they need to put together a strong...

Learn more →

European Disclosure Gateway

As part of its support for greater transparency, the pharmaceutical industry has voluntarily created a single point of access to help any interested stakeholder navigate the publicly available data on details of payments and other benefits in kind made by the industry to HCPs and HCOs across all EFPIA Members countries. Navigate the European Gateway map here!

What we are reading

Rare Diseases Moonshot partners welcome the pre-publication of the draft future Innovative... 14 June 2023 (Rare Disease Moonshot)

Innovative Health Initiative launches first five projects 14 June 2023 (IHI)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶